Using 3D models, new traction strategies in robotic liver surgery enhance visualization and efficiency. Integrating traction patterns improved stability during parenchymal transection in robotic liver resections. Demonstrated methods included coordinated traction techniques and simulation-based preoperative planning. Effective use of these strategies can improve outcomes and reduce complications in major hepatectomies. Journal Article by Kawano F, […]
Category: HPB & Spleen
Preoperative Biliary Drainage with Metal Stents Safe in Pancreatic Cancer
Preoperative biliary drainage (PBD) using self-expanding metal stents (SEMS) is noninferior to early surgery for pancreatic cancer patients, impacting surgical timing decisions. Serious adverse events were similar: 29.0% in PBD vs. 26.5% in early surgery (p = 0.011 for noninferiority). 82.6% of PBD patients had curative surgery versus 88.5% in the early surgery group. Surgeons […]
Robotic en bloc resection for pancreatic cancer is safe.
A robotic approach combined distal splenopancreatectomy and left nephrectomy in a complex case with renal infiltration from pancreatic adenocarcinoma. The procedure achieved negative margins and involved a multidisciplinary team to minimize conversion risk and enhance oncological outcomes. The patient was discharged on postoperative day 6, indicating a favorable recovery. Pathology revealed T4 cancer with two […]
Multivisceral Resection for Pancreatic Cancer: Comparable Outcomes
Multivisceral resection (MVR) for pancreatic ductal adenocarcinoma shows similar short-term outcomes to standard resection, but poorer long-term survival rates among selected patients. 2-year overall survival rate for MVR is 33.3% vs. 49.9% for standard resection (p=0.006). 2-year disease-free survival rate is 11.3% for MVR vs. 25.9% for standard resection (p=0.018). Surgeons should consider MVR for […]
Fragmented Care Impacts Pancreatic Cancer Outcomes
Fragmented care for pancreatic cancer patients at high-volume centers leads to delays in chemotherapy but not worse surgical outcomes. One-third of patients (n = 124) received fragmented care, often living farther from the center. Delayed chemotherapy initiation occurred in 17.6% of fragmented care patients compared to 5.6% of those receiving care solely at the center. […]
No Long-Term Outcome Difference in Gallbladder Cancer Resection
Surgeons can expect similar long-term outcomes when choosing between segment 4b/5 and wedge resection for gallbladder adenocarcinoma. 163 patients underwent randomized surgeries; segment 4b/5 took longer (318 min vs. 287 min) and had higher blood loss (265 ml vs. 223 ml). No differences in morbidity, mortality, or R0 resection rates were observed. At 27 months […]
New Biliary Drainage Technique for Altered Anatomy Shows Promise
A novel endoscopic approach improves biliary drainage outcomes for patients with altered anatomy. Technical success rate: 87.3%, clinical success: 93.8%. Adverse event rate: 20%, with 30.6% persistent fistula rate within 3 months. Consider this technique for patients with complex anatomy, especially when multiple biliary interventions are needed. Most common indication: benign strictures (58.2%). Multicenter Study […]
Improved Liver Retraction in Robotic Hepatectomy
A new technique for liver retraction during robotic surgery minimizes trauma and enhances surgical precision. Implemented in 26 robotic hepatectomies, the Clip-Pulley Maneuver (CPM) proved to be complication-free. No major events (Clavien-Dindo grade III or higher) were reported, and the diaphragm remained intact in all cases. This method allows real-time adjustments for optimal retraction without […]
Impact of Enhanced Recovery on Liver Surgery Outcomes
High compliance with enhanced recovery programs does not significantly improve survival after liver surgery. Among 1,860 patients, only 24.4% achieved high compliance. Twelve-month overall survival rates were similar: 96% for high compliance vs. 92% for low compliance (p = 0.11). Long-term mortality risks included metastatic disease and prolonged operative times. Only patients with colorectal liver […]
Robotic Taj Mahal Hepatectomy: A Game Changer for Type IV Cholangiocarcinoma
This study shows that robotic-modified Taj Mahal hepatectomy is a safe alternative for selected patients with type IV hilar cholangiocarcinoma, minimizing morbidity. Operative time was 560 minutes with only 300 ml blood loss. The postoperative course was smooth, with discharge on day 8 and no complications. This technique allows for a parenchyma-preserving approach, with one […]